Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Quipt Home Medical (TSE:QIPT)
TSX:QIPT
Earnings Data
Report Date
May 20, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
-0.02Last Year’s EPS
-0.04Same Quarter Last Year
Strong Buy
Based on 3 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Feb 10, 2025
|% Change Since: -16.63%
|Next Earnings Date:May 20, 2025
Earnings Call Sentiment|Neutral
The earnings call highlighted strong operational efficiency, particularly in adjusted EBITDA margin improvement, and consistent demand across product categories. However, revenue declined due to various headwinds, including contract terminations and regulatory changes. Despite these challenges, the company maintained a strong liquidity position and expressed confidence in future growth opportunities.Company Guidance
During the Quipt Home Medical Corporation's First Quarter 2025 Earnings Results Conference Call, the company provided several key financial metrics and insights into its strategic direction. For the first quarter, Quipt reported revenue of $61.4 million and an adjusted EBITDA of $14 million, reflecting a margin of 22.8%, which marked a sequential improvement. The company has expanded to 135 locations across 26 states, serving over 314,000 active patients and is focusing on respiratory care, which comprises 77% of its product mix. Quipt also highlighted its efforts in sleep apnea treatment, noting positive effects from GLP-1 medications on treatment adherence. The company is managing its balance sheet prudently, with a net leverage ratio of 1.5x, and is focused on driving organic growth, expanding market presence, and maintaining strong financial performance throughout fiscal 2025.Strong Adjusted EBITDA Margin Improvement
Achieved an adjusted EBITDA margin of 22.8% in fiscal Q1 2025, reflecting a sequential improvement and demonstrating operational efficiency.
Consistent Demand Across Major Product Categories
Reported stable demand and referral patterns across major product categories, with 221,000 unique setups and deliveries completed in the fiscal first quarter 2025.
Positive GLP-1 Impact on Sleep Business
GLP-1 medications showed no negative impact on the sleep business, with a study indicating a 10.7% increase in positive airway pressure therapy adherence among OSA patients.
Strong Liquidity Position
Maintained a conservative balance sheet with $47.9 million in liquidity and a net leverage ratio of 1.5x.
---
TSE:QIPT Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
TSE:QIPT Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Feb 10, 2025 | C$4.33 | C$4.21 | -2.77% |
| Dec 16, 2024 | C$4.38 | C$3.72 | -15.07% |
| Aug 14, 2024 | C$4.56 | C$3.77 | -17.32% |
| May 15, 2024 | C$5.40 | C$4.62 | -14.44% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Quipt Home Medical (TSE:QIPT) report earnings?
Quipt Home Medical (TSE:QIPT) is schdueled to report earning on May 20, 2025, TBA Not Confirmed.
What is Quipt Home Medical (TSE:QIPT) earnings time?
Quipt Home Medical (TSE:QIPT) earnings time is at May 20, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is TSE:QIPT EPS forecast?
TSE:QIPT EPS forecast for the fiscal quarter 2025 (Q2) is -0.02.
---